Bank of America
TARA icon

Bank of America’s Protara Therapeutics TARA Stock Holding History

Bank of America’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.82M Buy
925,918
+430,014
+87% +$2.55M ﹤0.01% 3503
2025
Q4 		$2.64M Buy
495,904
+315,429
+175% +$1.75M ﹤0.01% 3850
2025
Q3 		$785K Sell
180,475
-1,125
-0.6% -$3.64K ﹤0.01% 5488
2025
Q2 		$550K Sell
181,600
-107,117
-37% -$370K ﹤0.01% 5656
2025
Q1 		$1.23M Buy
288,717
+94,320
+49% +$421K ﹤0.01% 5075
2024
Q4 		$1.03M Buy
194,397
+194,031
+53,014% +$627K ﹤0.01% 5004
2024
Q3 		$670 Buy
366
+217
+146% +$446 ﹤0.01% 7322
2024
Q2 		$310 Buy
+149
New +$436 ﹤0.01% 7462
2024
Q1 		– Sell
-6
Closed -$11 – 8179
2023
Q4 		$11 Buy
+6
New +$9 ﹤0.01% 7765
2023
Q1 		– Sell
-22
Closed -$58 – 8260
2022
Q4 		$58 Buy
+22
New +$69 ﹤0.01% 7775
2022
Q2 		– Sell
-745
Closed -$3K – 8372
2022
Q1 		$3K Sell
745
-6,133
-89% -$32.2K ﹤0.01% 7994
2021
Q4 		$47K Buy
6,878
+6,356
+1,218% +$43.8K ﹤0.01% 7246
2021
Q3 		$3K Sell
522
-410
-44% -$3.2K ﹤0.01% 7841
2021
Q2 		$9K Sell
932
-3,168
-77% -$35.9K ﹤0.01% 7322
2021
Q1 		$65K Buy
4,100
+1,772
+76% +$32.9K ﹤0.01% 6544
2020
Q4 		$56K Buy
2,328
+550
+31% +$11.9K ﹤0.01% 6282
2020
Q3 		$30K Sell
1,778
-1,758
-50% -$40.8K ﹤0.01% 6195
2020
Q2 		$104K Sell
3,536
-4,535
-56% -$140K ﹤0.01% 5650
2020
Q1 		$186K Buy
8,071
+7,946
+6,357% +$231K ﹤0.01% 5125
2019
Q4 		$2K Buy
+125
New +$1.43K ﹤0.01% 6902
2019
Q3 		– Sell
-25
Closed – – 7494
2019
Q2 		$0 Buy
+25
New +$442 ﹤0.01% 7405
2019
Q1 		– Sell
-1
Closed – – 7402
2018
Q4 		$0 Buy
+1
New +$71 ﹤0.01% 7372
2016
Q3 		– Sell
-107
Closed -$34K – 7342
2016
Q2 		$34K Buy
107
+72
+206% +$21.5K ﹤0.01% 6008
2016
Q1 		$11K Buy
35
+30
+600% +$9.67K ﹤0.01% 6363
2015
Q4 		$3K Buy
5
+4
+400% +$2.35K ﹤0.01% 7027
2015
Q3 		$0 Sell
1
-4
-80% -$2.48K ﹤0.01% 7392
2015
Q2 		$4K Buy
+5
New +$3.09K ﹤0.01% 6897
2015
Q1 		– Sell
-3
Closed -$1K – 7542
2014
Q4 		$1K Buy
+3
New +$1.21K ﹤0.01% 7567

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Bank of America's TARA Position: Q1 2026 in Review

Bank of America increased its Protara Therapeutics (TARA) stake by 87% in Q1 2026, buying an estimated $2.55M and bringing the position to 925,918 shares worth $4.82M. The position accounts for ﹤0.01% of the portfolio, ranked #3503.

Bank of America first reported a position in TARA in Q4 2014 and has held it in 28 quarters since. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • Bank of America held 925,918 shares of Protara Therapeutics worth $4.82M as of Q1 2026.
  • Bank of America bought 430,014 Protara Therapeutics shares in Q1 2026, an estimated $2.55M.
  • Protara Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3503 holding.
  • Bank of America first reported a position in Protara Therapeutics in Q4 2014 and has held it in 28 quarters since.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.